Počet záznamov: 1
denosumab
SYS d000069448 LBL 00000nx^^^2200181-^^45^^ 005 20240119201449.9 100 $a 20160101asloy0103 ba0 152 $b mesh 250 $a denosumab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 2016 (2004) $8 eng 330 1-
$a A humanized monoclonal antibody and an inhibitor of the RANK LIGAND, which regulates OSTEOCLAST differentiation and bone remodeling. It is used as a BONE DENSITY CONSERVATION AGENT in the treatment of OSTEOPOROSIS. $8 eng 450 $a AMG 162 $5 e $8 slo 550 $3 sllk_un_auth*d053245 $Y RANK Ligand $5 F $a RANK ligand 550 $3 sllk_un_auth*d053245 $Y RANK Ligand $5 B $a RANK ligand 686 $a D12.776.124.486.485.114.224.060.782 686 $a D12.776.124.790.651.114.224.060.782 686 $a D12.776.377.715.548.114.224.200.782 750 $a Denosumab $8 eng 801 -0
$a SK $b BA006 $c 20160207 801 -2
$a SK $b BA006 $c 20160209 980 $x M
Počet záznamov: 1